DOES TREATMENT REVERSE THE NEUROCOGNITIVE AND CARDIOVASCULAR SEQUELAE OF SLEEP DISORDERED BREATHING IN CHILDREN?

治疗能否逆转儿童睡眠呼吸障碍的神经认知和心血管后遗症？

• 批准号: nhmrc : 1008919
• 负责人: A/Pr Gillian Nixon
• 金额: $ 34.66万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/does-treatment-reverse-breathing-children/109356
• 关键词: DOES; TREATMENT; REVERSE; NEUROCOGNITIVE; CARDIOVASCULAR

Studies in children have shown that disruption to normal sleep patterns resulting from sleep disordered breathing (SDB) has severe consequences for both the cardiovascular system and neurocognition. To date there have been no studies in children to investigate whether treatment of SDB with adenotonsillectomy, which has been shown to reduce sleep fragmentation and neurocognition, also reduces blood pressure.

对儿童的研究表明，睡眠呼吸障碍（SDB）对正常睡眠模式的破坏对心血管系统和神经认知都有严重的影响。迄今为止，还没有针对儿童的研究，以探讨采用腺扁桃体切除术治疗SDB是否也能降低血压。腺扁桃体切除术已被证明可以减少睡眠片段化和神经认知。